Peptides based on the presenilin-APP binding domain inhibit APP processing and Aβ production through interfering with the APP transmembrane domain
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peptides based on the presenilin-APP binding domain inhibit APP processing and Aβ production through interfering with the APP transmembrane domain
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 26, Issue 9, Pages 3765-3778
Publisher
FASEB
Online
2012-06-02
DOI
10.1096/fj.11-201368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sub-diffraction imaging on standard microscopes through photobleaching microscopy with non-linear processing
- (2012) S. Munck et al. JOURNAL OF CELL SCIENCE
- Design, synthesis and structure–activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors
- (2011) Danielle L. Aubele et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Excitotoxicity-induced endocytosis mediates neuroprotection by TAT-peptide-linked JNK inhibitor
- (2011) Anne Vaslin et al. JOURNAL OF NEUROCHEMISTRY
- ADP ribosylation factor 6 (ARF6) controls amyloid precursor protein (APP) processing by mediating the endosomal sorting of BACE1
- (2011) R. Sannerud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Age-Related Progressive Synaptic Dysfunction: The Critical Role of Presenilin 1
- (2011) Alexandra Auffret et al. REVIEWS IN THE NEUROSCIENCES
- NerveCenter: New evidence of preserved cognition in unresponsive TBI patient raises questions, concerns
- (2010) Kurt Samson ANNALS OF NEUROLOGY
- Novel Research Horizons for Presenilins and γ-Secretases in Cell Biology and Disease
- (2010) Bart De Strooper et al. Annual Review of Cell and Developmental Biology
- The Amyloid Precursor Protein C-Terminal Fragment C100 Occurs in Monomeric and Dimeric Stable Conformations and Binds γ-Secretase Modulators
- (2010) Anne Botev et al. BIOCHEMISTRY
- Alzheimer's Disease Neurons Fail the Acid Test
- (2010) Wim Annaert et al. CELL
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- REVIEW: γ-Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State
- (2010) Francesco Panza et al. CNS Neuroscience & Therapeutics
- TAT-mediated delivery of neuroglobin protects against focal cerebral ischemia in mice
- (2010) Bin Cai et al. EXPERIMENTAL NEUROLOGY
- Notch Signaling in the Immune System
- (2010) Freddy Radtke et al. IMMUNITY
- γ-secretases: from cell biology to therapeutic strategies
- (2010) Bruno A Bergmans et al. LANCET NEUROLOGY
- Alzheimer's failure raises questions about disease-modifying strategies
- (2010) Andy Extance NATURE REVIEWS DRUG DISCOVERY
- Her4 and Her2/neu Tyrosine Kinase Domains Dimerize and Activate in a Reconstitutedin VitroSystem
- (2009) John Monsey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
- (2008) Kavitha S. Rao et al. BIOMATERIALS
- Interaction between Reelin and Notch Signaling Regulates Neuronal Migration in the Cerebral Cortex
- (2008) Kazue Hashimoto-Torii et al. NEURON
- Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
- (2003) H. F. Dovey et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started